CD19 and acute lymphoblastic leukemia: We next addressed whether targeting module optimization of EVs shifts the endocytosis pathway of CD19/EV in B‐ALL target cells and how different endocytic routes impact EV‐mediated antigen depletion and cytotoxicity.